Cervical Dysplasia - Pipeline Review, H2 2014 market analysis - PowerPoint PPT Presentation

View by Category
About This Presentation
Title:

Cervical Dysplasia - Pipeline Review, H2 2014 market analysis

Description:

To Get More Info. Visit: Cervical Dysplasia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Cervical Dysplasia - Pipeline Review, H2 2014’, provides an overview of the Cervical Dysplasia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Cervical Dysplasia, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. – PowerPoint PPT presentation

Number of Views:25

less

Write a Comment
User Comments (0)
Transcript and Presenter's Notes

Title: Cervical Dysplasia - Pipeline Review, H2 2014 market analysis


1
Cervical Dysplasia - Pipeline Review, H2 2014
No. Pages 66
Published on Dec-2014
2
Report Description
Cervical Dysplasia - Pipeline Review, H2 2014
Summary Global Markets Directs, Cervical
Dysplasia - Pipeline Review, H2 2014, provides
an overview of the Cervical Dysplasias
therapeutic pipeline. This report provides
comprehensive information on the therapeutic
development for Cervical Dysplasia, complete with
comparative analysis at various stages,
therapeutics assessment by drug target, mechanism
of action (MoA), route of administration (RoA)
and molecule type, along with latest updates, and
featured news and press releases. It also reviews
key players involved in the therapeutic
development for Cervical Dysplasia and special
features on late-stage and discontinued projects.
Global Markets Directs report features
investigational drugs from across globe covering
over 20 therapy areas and nearly 3,000
indications. The report is built using data and
information sourced from Global Markets Directs
proprietary databases, Company/University
websites, SEC filings, investor presentations and
featured press releases from company/university
sites and industry-specific third party sources,
put together by Global Markets Directs
team. To Get More Info. Visit
http//www.analyzefuture.com/cervical-dysplasia-pi
peline-review-h2-2014-market
3
Report Description
Drug profiles/records featured in the report
undergoes periodic updation following a stringent
set of processes that ensures that all the
profiles are updated with the latest set of
information. Additionally, processes including
live news deals tracking, browser based
alert-box and clinical trials registries tracking
ensure that the most recent developments are
captured on a real time basis. To Enquire Visit
_at_ http//www.analyzefuture.com/cervical-dysplasi
a-pipeline-review-h2-2014-market/report-enquiry T
he report enhances decision making capabilities
and help to create effective counter strategies
to gain competitive advantage. It strengthens RD
pipelines by identifying new targets and MOAs to
produce first-in-class and best-in-class
products. Note Certain sections in the report
may be removed or altered based on the
availability and relevance of data for the
indicated disease. Scope - The report provides a
snapshot of the global therapeutic landscape of
Cervical Dysplasia - The report reviews key
pipeline products under drug profile section
which includes, product description, MoA and RD
brief, licensing and collaboration details
other developmental activities
4
Table of Content
Table Of ContentsTable of ContentsTable of
Contents 2List of Tables 4List of Figures
4Introduction 5Global Markets Direct Report
Coverage 5Cervical Dysplasia Overview
6Therapeutics Development 7Pipeline Products
for Cervical Dysplasia - Overview 7Pipeline
Products for Cervical Dysplasia - Comparative
Analysis 8Cervical Dysplasia - Therapeutics
under Development by Companies 9Cervical
Dysplasia - Therapeutics under Investigation by
Universities/Institutes 10Cervical Dysplasia -
Pipeline Products Glance 11Clinical Stage
Products 11Early Stage Products 12
5
Table of Content
Cervical Dysplasia - Products under Development
by Companies 13Cervical Dysplasia - Products
under Investigation by Universities/Institutes
14Cervical Dysplasia - Companies Involved in
Therapeutics Development 15CEL-SCI Corporation
15Helix Bio Pharma Corp. 16Inovio
Pharmaceuticals, Inc. 17PDS Biotechnology
Corporation 18VLPbio 19Cervical Dysplasia -
Therapeutics Assessment 20Assessment by
Monotherapy Products 20Assessment by Target
21Assessment by Mechanism of Action
23Assessment by Route of Administration
25Assessment by Molecule Type 27Drug Profiles
29CerviVax - Drug Profile 29Product Description
29Mechanism of Action 29RD Progress 29
6
Table of Content
CIGB-228 - Drug Profile 30Product Description
30Mechanism of Action 30RD Progress
30interferon alpha-2b (recombinant) - Drug
Profile 31Product Description 31Mechanism of
Action 31RD Progress 31Leukocyte Interleukin -
Drug Profile 33Product Description 33Mechanism
of Action 33RD Progress 33PDS-0101 - Drug
Profile 36Product Description 36Mechanism of
Action 36RD Progress 36Vaccine for Cervical
Intraepithelial Neoplasia - Drug Profile 37
7
Table of Content
Product Description 37Mechanism of Action 37RD
Progress 37VGX-3100 - Drug Profile 39Product
Description 39Mechanism of Action 39RD
Progress 39Cervical Dysplasia - Recent Pipeline
Updates 40Cervical Dysplasia - Dormant Projects
53Cervical Dysplasia - Discontinued Products
54Cervical Dysplasia - Product Development
Milestones 55 To Get Complete TOC Visit at
http//www.analyzefuture.com/cervical-dysplasia-pi
peline-review-h2-2014-market/table-of-contents U
pcoming Reports http//www.analyzefuture.com/n
erve-repair-regeneration-market
8
FOR MORE DETAILS
Visit us at
http//www.analyzefuture.com/
Stay With Us
5933 NE Win Sivers Drive, 205, Portland, OR
97220 United States.
TELEPHONE 1 (855) 711-1555 EMAIL
sales_at_analyzefuture.com
About PowerShow.com